Provident Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-447,549
| Closed | -$41.3M | – | 81 |
|
|
2024
Q2 | $41.3M | Sell |
447,549
-5,781
| -1% | -$534K | 3.76% | 16 |
|
|
2024
Q1 | $43.3M | Sell |
453,330
-2,400
| -0.5% | -$229K | 3.82% | 17 |
|
|
2023
Q4 | $34.7M | Buy |
455,730
+6,837
| +2% | +$521K | 3.28% | 15 |
|
|
2023
Q3 | $31.1M | Buy |
448,893
+16,742
| +4% | +$1.16M | 3.43% | 15 |
|
|
2023
Q2 | $40.8M | Sell |
432,151
-525
| -0.1% | -$49.5K | 4.31% | 14 |
|
|
2023
Q1 | $35.8M | Buy |
+432,676
| New | +$35.8M | 3.88% | 16 |
|